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Introduction
There is a compelling need to improve currently available therapies for severe and chronic pain [1, 2] . Voltage-gated ion channels located on sensory neurons are involved in the transmission of pain signals to the central nervous system for interpretation and response. Some sub-types of the human voltage-gated sodium channels (hNa V s), including the sub-type 1.7 (hNa V 1.7), have been linked to pain [3, 4] . Loss of function mutations on SCN9A, the gene encoding hNa V 1.7, result in unresponsiveness to pain, whereas gain of function mutations result in increased chronic and acute pain sensations [3, 4] . Because of this link to pain, efforts to identify potent and selective inhibitors of hNa V 1.7 are underway [5] [6] [7] [8] .
Peptide toxins isolated from spider venoms have shown promising potency for inhibiting hNa V 1.7 and therefore have potential as therapeutic leads [9] . Most of these toxins modify the kinetics and gating behavior of voltage-gated ion channels and alter the relative stability of the closed, open or inactivated states of the channels. The peptide toxins are thus classified as gating modifier toxins (GMTs) [10] .
GMTs typically have a conserved amino acid arrangement resulting in a surface profile comprising a hydrophobic patch surrounded by a ring of charged residues (Figure 1B) [9, 11] . Structure activity relationship studies between the toxins and their target channels reveal that this surface motif appears to be involved in the binding of GMTs to target residues on the voltage-gated ion channels and that these peptides recognize overlapping target residues on the channels [12] [13] [14] . For example, the channel binding region of ProTx-II has been determined to bind to F813, D816 and E818 on hNa V 1.7, whereas HwTx-IV has been shown to interact with E811, L814, D816, E818 on the same channel [15, 16] . This raises the possibility that the toxins, rather than recognizing specific channel residues, identify a local binding site on the voltage sensor domain that is structurally and chemically complementary to the surface motif of the GMTs [12, 17] .
ProTx-II is an example of a GMT whose inhibitory activity has been suggested to be dependent on ability of the peptide to bind to lipid membranes [18] . This mechanistic suggestion is based on studies showing that ProTx-II analogues with reduced or no binding affinity to lipid membranes were shown to be inactive against hNa V 1.7 whereas native ProTx-II, a potent inhibitor of hNa V 1.7 (IC 50 = 0.3 nM) showed affinity for lipid membranes [18] . Interestingly, HwTx-IV, despite showing a high potency at hNa V 1.7 (IC 50 = 27 nM), binds poorly to tested model membranes [19] . In the current study we examined whether
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5 engineering a HwTx-IV analogue with increased ability to bind to lipid membranes would improve its inhibitory potency at hNa V 1.7 ( Figure 1C ). Biophysical studies were used to characterize peptide-membrane binding on model membranes and inhibitory potency at hNa V 1.7 was studied using bioassays on SH-SY5Y neuroblastoma cells. The combined results showed that increasing the membrane binding affinity of HwTx-IV also increased the inhibitory potency of the peptide toxin and these insights have the potential for translation to the design of analgesic inhibitors of hNa V 1.7.
Materials and methods

Peptide synthesis and folding
HwTx-IV, mHwTx-IV and gHwTx-IV (Figure 1C HwTx-IV and mHwTx-IV were oxidized overnight at room temperature at a concentration of 0.1 mg/mL in 0.1 M Tris-HCl (pH 8), 0.1 M NaCl, 5 mM reduced glutathione and 0.5 mM oxidized glutathione [20] . Oxidation reactions were monitored using LC/MS and quenched with solvent A (0.05% v/v TFA) to 1:2 (v/v). gHwTx-IV was dissolved in 50% v/v ACN prior to drop-wise addition to a buffer consisting of 0.1 M Tris-HCl, 10% v/v filtered isopropanol (pH 8), 5 mM reduced glutathione and 1 mM oxidized glutathione bringing the final peptide concentration to 0.05 mg/mL. The reaction was quenched by lowering the pH to pH 2 using ACN/TFA/water (1:1:1) (v/v/v) [21] .
Oxidized peptides were purified using a linear gradient of 10-70% solvent B over 60 min at 8 mL/min and further separated at 3 mL/min on a gradient of 20-50% solvent B over 60 min. Fractions were collected and analyzed by ESI-MS. Fractions containing the molecular mass corresponding to the oxidized peptide were pooled, lyophilized and stored at -20 °C.
Peptide samples were quantified by absorbance at 280 nm using Nanodrop. Extinction coefficients 
NMR spectroscopy
HwTx-IV, mHwTx-IV and gHwTx-IV were dissolved in 90% (v/v) H 2 O and 10% (v/v) D 2 O to a concentration of ~1mg/mL at pH ~4. Experiments, including one-dimensional (1D) 1 H spectra and twodimensional (2D) total correlated spectroscopy (TOCSY) (80 ms mixing time) and nuclear Overhauser effect spectroscopy (NOESY) (200 ms mixing time) were acquired on a Bruker Avance 600 MHz nuclear magnetic resonance (NMR) spectrometer equipped with a cryoprobe at 298 K to confirm correct folding of the peptides. Spectra were processed using TopSpin (Bruker), referenced to water at 4.76 ppm, and the peptide sequences were sequentially assigned using CCPNMR Analysis 2.4.1 [22, 23] .
Additional NMR data were collected for the solution structure determination of gHwTx-IV, gHwTx-IV were used to generate a list of inter-proton distances using the AUTO function in CYANA 3.97 [24] . Several rounds of AUTO calculations were used to refine peak assignments. Constraints for and backbone dihedral angles were generated with TALOS-N using H , C , C , HN chemical shifts derived from NOESY, 1 H-13 C HSQC and 1 H-15 N HSQC spectra [25] . H-bond restraints derived from temperature coefficient experiments and D 2 O exchange experiments and 1 side chain dihedral angle restraints derived from E.COSY in combination with NOE intensities were included in structure calculations using the
ANNEAL function in CYANA. Protocols in the RECOORD database were used in CNS to calculate 50 structures, which were further refined in a water shell [26, 27] . 
Molecular modelling of HwTx-IV and gHwTx-IV
Solvent accessible surface area (SASA), residual dipole moments and electrostatic surface potentials of HwTx-IV and gHwTx-IV were calculated and analysed using the following molecular modelling tools.
Polar and apolar SASA of the GMTs was calculated on GetArea using the default 1.4 Å water probe [29] .
As HwTx-IV and gHwTx-IV are charged molecules, the dipole of these molecules is not formally defined and any calculated dipole is dependent on the translation or rotation of the peptides with respect to the origin. To facilitate a qualitative comparison between HwTx-IV and gHwTx-IV, the residual dipole moment, which is independent of position or rotation in space [30] , was used. The residual dipole moment of HwTx-IV and gHwTx-IV was calculated using the g_dipoles tool on GROMACS version 5.1.12 in which the net charge is subtracted at the center of mass of the peptides [31] . Electrostatic surface potentials were calculated by solving the linearized Poisson-Boltzmann equation using the APBS software [32] . The PDB files of HwTx-IV (PDB ID: 2M4X) and gHwTx-IV (PDB ID: 5TLR) were processed using the PDB2PQR online server with the AMBER force field [33] , and ProPka was used to assign protonation states of the side chains at a pH of 7.4 [27] . The electrostatic surface potential was visualized using the APBS plugin on PyMOL [34, 35] . 
Preparation of lipid vesicles
150 mM NaCl, pH 7.4), submitted to eight freeze-thaw cycles and extruded through 50 nm or 100 nm pore sized polycarbonate filters to obtain small unilamellar vesicles (SUVs) or large unilamellar vesicles (LUVs)
respectively. SUVs were used for the surface plasmon resonance (SPR) studies as their small radii facilitate the formation of lipid bilayers when deposited onto the L1 SPR sensor chip. LUVs were used for fluorescence experiments as their large radii create a more planar surface to mimic the physiological lipid bilayers [36, 37] .
Peptide-membrane kinetic and affinity studies using SPR
SPR was used to examine peptide-membrane binding kinetics and affinity. Experiments were conducted at 25 °C using a Biacore 3000 instrument and an L1 sensor chip. HBS was used to prepare the peptide and lipid samples and as running buffer. Lipid bilayers were deposited onto the surface of the L1 sensor chip for 2600 s at a flow rate of 2 L/min as previously described [18] . Peptide samples (concentrations ranging from 0-64 M) were injected over the lipid surface for 180 s at a flow rate of 5 μL/min for the association phase. The dissociation phase lasted 600 s per injection cycle. Data were corrected for buffer contribution and normalized by assuming that 1 response unit (RU) = 1 pg/mm 2 of lipid deposited, and subsequent peptide binding as previously described [38] . Peptide-lipid membrane binding was analysed using non-linear regression one-site specific binding curves on Prism 7. Binding kinetics were studied by fitting the data of peptides at 32 M to association then dissociation curves based on the 1:1
Langmuir model [39] .
Peptide-membrane binding followed by Trp fluorescence
The peptides used in this study are intrinsically fluorescent due to the presence of Trp residue(s) in their sequences. Trp fluorescence emission spectra were therefore used to examine whether the Trp residue(s) of the peptides insert into the lipid bilayers [40] . Peptides and L-Trp (12.5 M in HBS) were titrated with POPC/POPS (4:1) LUV suspensions to attain final lipid concentrations ranging from 0-4 mM.
Fluorescence emission spectra were obtained upon excitation at 280 nm using a Perkin Elmer luminescence LS spectrometer with slits set to 3/3 nm. Peptide spectra were corrected for dilution due to titration with LUV suspensions and blanks were subtracted to examine changes in Trp fluorescence quantum yield.
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To examine whether the peptide Trp residues are solvent exposed when the peptides are in the presence or absence of LUVs, samples of GMTs or L-Trp (12.5 M in HBS) with or without 1 mM POPC/POPS (4:1) LUVs were titrated with acrylamide, an aqueous quencher, in concentrations ranging from 0-100 mM. Fluorescence emission intensity, upon excitation at 290 nm and emission at the wavelength at which the sample showed maximum emission (around 350 nm), was followed upon titration with acrylamide [40] . Data were corrected for dilution by titration with acrylamide and for dispersion from the lipid analysed using the Stern-Volmer equation [40] .
Inhibition of hNa V 1.7 induced by HwTx-IV and its analogues
The inhibitory potency of HwTx-IV and two analogues on hNa V 1.7 was assessed using a calcium assay on a Fluorimetric Imaging Plate Reader (FLIPR TETRA ) assay as previously described [41] . SH-SY5Y cells expressing hNa V 1.7 were maintained in RPMI medium supplemented with 15% (v/v) fetal bovine serum (FBS), 100 units/mL penicillin, 100 units/mL streptomycin and 2 mM L-glutamine, with subculturing every 72 h (70-80% confluence).
SH-SY5Y cells were plated onto 96 well black-walled Corning™ imaging plates at a density of 65,000 cells/well 72 h prior to FLIPR TETRA assays. Immediately prior to assays, media was removed and cells were washed in physiological salt solution (PSS: 140 mM NaCl, 11.5 mM glucose, 5.9 mM KCl, 1.4 mM MgCl 2 , 1.2 mM NaH 2 PO 4 , 5 mM NaHCO 3 , 1.8 mM CaCl 2 and 10 mM HEPES, pH 7.4). The SH-SY5Y cells were then incubated for 30 min at 37 °C with FLIPR calcium 4 dye, 30 nM of OD1 (a selective modulator of hNa V 1.7 inactivation), and 0.1% (w/v) bovine serum albumin (BSA) diluted in PSS buffer as previously described [41] . Peptides were prepared to achieve final concentrations ranging from 3 M to 1.7 10 -5 M in PSS with 0.1% (w/v) BSA. The Na V 1.7 agonist, veratridine, was prepared to achieve a final concentration of 4 M in PSS with 0.1% (w/v) BSA. Test peptides were added to the cells and incubated for an additional 15 min using the FLIPR TETRA instrument at 25 °C. Fluorescence emission intensity (excitation 470-495 nm; emission 515-575 nm) was recorded every second for ten initial baseline reads, followed by the addition of veratridine. Fluorescence emission intensity (a measure of calcium influx into the cells
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10 following veratridine activation of hNa V 1.7) was then recorded every second for 300 s and the raw data were corrected for the contribution of buffer and transformed to maximal response over baseline using Screenworks 3.1.1.4 (Molecular Devices). Data were normalized to the maximal change in fluorescence emission for each peptide prior to analysis on Prism 7 using one-site specific binding with Hill slope and Bmax = 1.
Results
The purpose of this study was to determine whether increasing the membrane binding properties of HwTx-IV would increase its inhibitory at hNa V 1.7. To achieve this goal, two analogues of HwTx-IV,
[EPyrE]HwTx-IV (mHwTx-IV) and [E1G,E4G,F6W,Y33W]HwTx-IV (gHwTx-IV), were studied ( Figure   1C ). mHwTx-IV is a naturally occurring derivative of HwTx-IV characterized by a post-translational modification conferring a pyroglutamic acid (PyrE) residue at position 1. The E1PyrE modification on mHwTx-IV has been determined previously to result in a longer duration of inhibition of hNa V 1.7 [42] .
gHwTx-IV is a derivative of another HwTx-IV analogue: [E1G,E4G,Y33W]HwTx-IV, shown previously to have increased potency at hNa V 1.7 (IC 50 = 0.4 nM) compared to HwTx-IV (IC 50 = 27 nM) [21] .
Peptide synthesis and NMR analyses on HwTx-IV, mHwTx-IV and gHwTx-IV
All peptides in this study were successfully synthesized and oxidized with final yields of > 90% for
HwTx-IV and mHwTx-IV and approximately 10% for gHwTx-IV. 1D 1 H and 2D TOCSY and NOESY spectra were obtained for HwTx-IV, mHwTx-IV and gHwTx-IV. All peptides were confirmed to be folded as was evidenced by well dispersed peaks in the amide region (7-10 ppm) of the 1D 1 H spectra. TOCSY and NOESY spectra were then used for the successful sequential assignment of individual amino acid spin systems [23] . H chemical shifts were used to compare mHwTx-IV and gHwTx-IV to native HwTx-IV.
Overall, there were minimal chemical shift differences except at, or near positions on mHwTx-IV and gHwTx-IV where sequence modifications were present ( Figure 2A ). This observation indicated that the three synthetic peptides have similar overall structures and the same disulfide connectivity.
The NMR solution structure of gHwTx-IV was calculated and refined using CYANA and CNS. The Table 1 ). The solution structure of gHwTx-IV was characterised by an ICK motif typical of spider derived GMTs [9] . The ICK structure featured loops and turns as well a pair of short antiparallel beta sheets between residues 23-24 and 31-32; features common to ICK peptides [43] .
Peptide-lipid bilayer kinetic and affinity studies using SPR
Peptide-lipid bilayer interactions of HwTx-IV and its analogues were studied using SPR and model membranes of varying charge and fluidity. Choice of model membranes in this study was based on features of the eukaryotic cell membrane, which exists as a heterogeneous fluid bilayer. Phospholipids containing a phosphatidylcholine headgroup are the most abundant lipids in eukaryotic cell membranes, thus vesicles composed of POPC, which forms zwitterionic fluid model membranes at 25 C, were used as an initial simple model membrane [44] . Negatively-charged vesicles composed of POPC/POPS (4:1) were used to examine the importance of electrostatic interactions between the peptide and the membrane and to mimic the effect of having negatively-charged molecules at the cell surface. Although the lipids that compose the outer leaflet of the cell membrane are primarily neutrally charged, there are anionic molecules present in the outer leaflet of physiological membranes [44] (e.g. extracellular regions of Na V channels and proteoglycans that possess a serine to which glycosaminoglycan chains are attached to [45] ). The membrane environments in the vicinity of ion channels are proposed to have lipids arranged in domains (rafts) whose compositions typically have high proportions of CHOL and SM; furthermore, studies have shown that the venoms of some spiders have enzymes that drive the conversion of SM to the anionic ceramide-1-phosphate (C1P) [46, 47] .
Therefore, the neutrally charged, POPC/SM/CHOL (2.7:4:3.3) and anionic POPC/C1P/CHOL (2.7:4:3.3 molar ratio) model membranes were also studied [48, 49] .
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The SPR data showed that gHwTx-IV has higher affinity and binding maxima in the four model membranes studied when compared to HwTx-IV and mHwTx-IV ( Figure 3A, B) . Furthermore, gHwTx-IV had preferential interactions (higher binding maxima and slower dissociation-rates) with the anionic POPC/POPS (4:1) and POPC/C1P/CHOL (2.7:4:3.3), in comparison to neutral POPC and POPC/SM/CHOL (2.7:4:3.3) model membranes ( Table 2) .
In-depth location of peptide Trp residues within the lipid membrane
Fluorescence emission of Trp residues on peptides is sensitive to the surrounding environment; thus Figure 3C ). These results show that in the presence of lipid, the Trp residues on gHwTx-IV become less exposed to the aqueous environment, and suggest that the residues are involved in the binding of the peptide to the lipid bilayer.
Acrylamide is a water-soluble quencher of fluorescence emission from Trp residues on peptides and is unable to partition into lipid bilayers and thus can only efficiently quench fluorescence emission of Trp residues that are aqueous exposed. When Trp residues on peptides insert into lipid membranes they are protected from acrylamide quenching; therefore, the Trp fluorescence quenching efficiency by acrylamide in the presence of lipid vesicles was examined to give information on the position of the Trp residues when the peptides interact with lipid bilayers. The quenching efficiency of acrylamide was compared using the Stern Volmer constant (K SV ) [37, 40] . Acrylamide efficiently quenched the fluorescence emission of the Trp residues of HwTx-IV and gHwTx-IV in buffer suggesting that the Trp residues of the peptides are solvent ( Figure 3D ). The small difference in K SV values suggests that the Trp residues in gHwTx-IV have a shallow position when bound to lipid membranes such that the residues are still accessible to acrylamide.
Comparison of charge and surface properties of HwTx-IV and gHwTx-IV
To examine the features that confer gHwTx-IV with the ability to interact with lipid bilayers, we compared the net charge, residual dipole moment, solvent accessible surface area (SASA), electrostatic surface potentials and chemical surface profiles of gHwTx-IV and HwTx-IV. It can be expected that mHwTx-IV would show similar surface properties to HwTx-IV given the overall similarity in their structures based on secondary H shifts, and the only charge difference being the absence of a Glu residue at position 1 ( Figure 2A ). gHwTx-IV, on the other hand, has a higher net charge (+6 compared to +4 for HwTx-IV) as well as a higher residual dipole moment and more apolar SASA than HwTx-IV (Table 3) . A surface profile comparison showed that gHwTx-IV had a larger hydrophobic surface area than HwTx-IV ( Figure 5A ). Furthermore, a comparison of the GMT electron density distributions showed that the surface of gHwTx-IV possessing the mutations was more positive than the same surface on HwTx-IV ( Figure 5B ).
These results are attributable to the replacement of the anionic E1, E4, with the apolar G1, and G4 and the replacement of F6, Y33 more hydrophobic W6 and W33.
Inhibitory activity of HwTx-IV, mHwTx-IV and gHwTx-IV at hNa V 1.7
To determine whether gHwTx-IV, the analogue that showed increased lipid bilayer interactions, would also show increased inhibitory activity at hNa V 1.7, the FLIPR calcium 4 assay was performed using SH-SY5Y neuroblastoma cells as previously described [41] . The three peptides slowed down the activation kinetics of hNa V 1.7 ( Figure 4A ). HwTx-IV (IC 50 = 32.4 ± 4.7 nM) and mHwTx-IV (IC 50 = 30.8 ± 5.2 nM) had similar inhibitory activity; whereas gHwTx-IV showed an increase in inhibitory potency (IC 50 = 7.6 ± 1.5 nM) at hNa V 1.7 ( Figure 4B ).
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Discussion
The structures of GMTs isolated from spiders are typically characterized by a conserved hydrophobic patch surrounded by a charged ring. This structural feature has been proposed to promote not only GMT-voltage-gated ion channel interactions, but also GMT-lipid membrane interactions [12, 13, 17, 18, 48] . Several spider GMTs have been shown to interact with model membranes and the unique structures of these peptides have been proposed to facilitate a tri-molecular interaction involving the GMTs, the lipid membrane and target voltage-gated ion channels [14, 47, [50] [51] [52] . HwTx-IV is a potent inhibitor of hNa V 1.7;
however, this GMT has been reported to have a weak affinity for lipid membranes [16, 19] . In this study we confirm that HwTx-IV has weak membrane affinity and we compare the peptide to two analogues, mHwTx-IV and gHwTx-IV. Results from membrane binding studies and activity assays show that mHwTx-IV has similar weak membrane binding interactions to HwTx-IV and a nearly identical inhibitory potency at hNa V 1.7. In contrast, gHwTx-IV simultaneously displays increased inhibitory activity at hNa V 1.7 and increased interactions with lipid membranes.
Peptide-lipid membrane interactions were studied in fluid and raft-like model membranes of both anionic and zwitterionic overall charges. In comparison to HwTx-IV and mHwTx-IV, which showed similar weak interactions with the model membranes, gHwTx-IV consistently showed the highest affinity to all model membranes tested ( Figure 3A, B) . Furthermore, acrylamide quenching of the fluorescence emission of Trp residues on the peptides suggested that gHwTx-IV adopts a superficial position on the membrane ( Figure 3D ). This position on the membrane surface is likely to be facilitated by a combination of electrostatic, hydrogen bonding and hydrophobic interactions between the peptide and the phospholipid headgroups of the lipid membrane. Several prior GMT-membrane binding studies have proposed that the hydrophobic patch present on these spider toxins is important for hydrophobic interactions with the membrane and that the charged ring of these spider derived peptides participates in electrostatic interactions with the phospholipid headgroups [18, [53] [54] [55] . The importance of electrostatic interactions between gHwTx-IV and the lipid membrane is supported by the observation that gHwTx-IV has a higher affinity for anionic lipid membranes (Figure 3 A, B) . Furthermore, a global profile of the electrostatic surface potential on the surface of gHwTx-IV containing the four mutations (E1G, E4G, F6W and Y33W) is more positive than the
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
15 same surface on HwTx-IV ( Figure 5B) , and gHwTx-IV has a higher net charge and residual dipole moment than HwTx-IV (Table 3) . Together these features can promote GMT electrostatic interactions with the phospholipid headgroups of the membrane. The interactions between gHwTx-IV and the lipid membrane are likely also facilitated by hydrogen bonding between the indole groups on the side chains of W6 and W33, and the phospholipid headgroups of the membrane. Additionally, hydrophobic interactions could also play a role in the gHwTx-IV-lipid membrane interaction as is evidenced from the findings that gHwTx-IV has a larger hydrophobic patch ( Figure 5A ) and apolar SASA (Table 3) than HwTx-IV.
In addition to increased membrane interactions, gHwTx-IV showed a 4-fold increase in inhibition of hNa V 1.7 compared to both HwTx-IV and mHwTx-IV, which had similar inhibitory potencies. In a previous structure-activity relationship (SAR) study with an alanine scan of HwTx-IV, a region at the surface of the molecule was proposed to be responsible for the interaction with hNa V 1.7 [12] . Specifically, it was suggested that the amino acid residues R26, K27 and K32 on HwTx-IV interact with D816, E818 and E811
on the extracellular loop of voltage sensor domain II of hNa V 1.7 ( Figure 6 ) [12] . Our studies with gHwTx-IV suggest that the combination of the mutations E1G, E4G, F6W and Y33W result in both increased membrane binding and increased inhibition of hNa V 1.7. These four mutations are part of a hydrophobic patch located at the surface of the molecule distinct from the surface formed by the channel binding residues R26, K27 and K32 ( Figure 6A ).
We propose that the increased potency observed with gHwTx-IV, compared to HwTX-IV, is facilitated by membrane-binding interactions. Briefly, electrostatic interactions between gHwTx-IV and the membrane would attract the peptide to the membrane surface and additional hydrogen bonding and hydrophobic interactions would orient the peptide such that the face containing R26, K27 and K32 is available for interactions with hNa V 1.7 ( Figure 6 ). In addition, the overall decrease in anionic charge and increase in hydrophobicity of gHwTx-IV might further augment interactions between the peptide and hNa V 1.7 This hypothesis was previously proposed by Revell and colleagues [13] , when the authors observed an increase in the inhibitory potency of the analogue [E1G,E4G,Y33W]HwTx-IV [21] . In silico docking studies suggested that the residues F6 and Y33 form hydrophobic interactions with M750 on hNa V 1.7; thus, a supporting explanation for the increased activity observed with gHwTx-IV is that the mutations F6W and
16
Y33W would improve the hydrophobic interaction with M750 due to the increased hydrophobic character of tryptophan compared to that of phenylalanine and tyrosine [12, 56] . Although we cannot exclude the possibility that an increased inhibitory potency on hNa V 1.7 and increased membrane binding are independent, we propose a model where gHwTx-IV acts by binding both to the membrane and to the target channel ( Figure 6B) . A similar mechanism has been suggested for ProTx-I and ProTx-II, two GMTs that also seem to possess distinct surface regions responsible for membrane interaction and for channel interaction [18, 48] . Furthermore, the fact the amino acid residues that seem to be involved in membrane binding are distinct from those involved in channel binding lead us to postulate that gHwTx-IV will show a similar selectivity profile to HwTx-IV, particularly against Na V 1.5 which is involved in cardiac muscle conduction [16] . This hypothesis is further supported by [E1G,E4G,Y33W]HwTx-IV, an analogue similar to gHwTx-IV, which was found to be inactive at Na V 1.5 [21] .
We conclude that by engineering HwTx-IV to increase membrane interactions, we have simultaneously designed a peptide with higher activity at hNa V 1.7. Overall charge and hydrophobicity play important roles both in interactions of gHwTx-IV with hNa V 1.7 and with lipid membranes. Two predominant theories for GMT-membrane interactions are that the lipid bilayer acts to concentrate the peptide at the active site for the purpose of increasing peptide availability at the channel active site and secondly that GMT-membrane interactions facilitate access to the voltage sensor domain, which rests at a superficial position in the bilayer [57, 58] . The way forward is therefore to study GMTs, model membranes and channels in concert to better understanding of the mechanism of action of this tri-molecular complex, with the aim of developing peptides with higher inhibitory potency at hNa V 1.7. A C C E P T E D M A N U S C R I P T A C C E P T E D M A N U S C R I P T potencies. An apparent inhibition of hNa V 1.7 at low concentrations is evident on the curve and is a false positive effect often seen at low peptide concentrations. II and pore of hNa V 1.7 channel is shown highlighting gHwTx-IV, the voltage sensor domain II, and the key residues identified as important for the activity of HwTx-IV (E811, D816 and E818 ) are underlined [12] .
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